Head to Head Contrast: Cadre (NYSE:CDRE) & Demant A/S (OTCMKTS:WILYY)

Demant A/S (OTCMKTS:WILYYGet Rating) and Cadre (NYSE:CDREGet Rating) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, earnings, risk and institutional ownership.

Insider and Institutional Ownership

33.6% of Cadre shares are owned by institutional investors. 52.9% of Cadre shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of recent recommendations and price targets for Demant A/S and Cadre, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Demant A/S 1 2 2 0 2.20
Cadre 0 1 6 0 2.86

Cadre has a consensus target price of $26.17, suggesting a potential upside of 4.92%. Given Cadre’s stronger consensus rating and higher probable upside, analysts plainly believe Cadre is more favorable than Demant A/S.

Profitability

This table compares Demant A/S and Cadre’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Demant A/S N/A N/A N/A
Cadre -1.59% 7.60% 1.97%

Valuation & Earnings

This table compares Demant A/S and Cadre’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Demant A/S $2.93 billion 2.42 $399.82 million N/A N/A
Cadre $427.29 million 2.18 $12.66 million ($0.24) -103.91

Demant A/S has higher revenue and earnings than Cadre.

Summary

Cadre beats Demant A/S on 7 of the 11 factors compared between the two stocks.

About Demant A/S

(Get Rating)

Demant A/S, a hearing healthcare and audio technology company, develops, manufactures, and sells products and equipment to enhance people's hearing in Europe, North America, the Pacific, Asia, and internationally. It operates in two segments, Hearing Healthcare and Communications. The Hearing Healthcare segment offers hearing implants and aids, hearing care, and diagnostic products. The Communications segment provides headsets for collaborative work and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

About Cadre

(Get Rating)

Cadre Holdings, Inc. manufactures and distributes safety and survivability equipment that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It primarily provides body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brands; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective and law enforcement equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, and various foreign government agencies. The company was founded in 1964 and is headquartered in Jacksonville, Florida.

Receive News & Ratings for Demant A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Demant A/S and related companies with MarketBeat.com's FREE daily email newsletter.